Annual Drug Patent Expirations for INVEGA+SUSTENNA
Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
INVEGA SUSTENNA drug price trends.
Drug patent litigation for INVEGA SUSTENNA.
This drug has twenty-four patent family members in seventeen countries.
The generic ingredient in INVEGA SUSTENNA is paliperidone palmitate. One supplier is listed for this compound. Additional details are available on the paliperidone palmitate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
